RNA targeting by DNA binding drugs: Structural, conformational and energetic aspects of the binding of quinacrine and DAPI to A-form and HL-form of poly(rC)·poly(rG)
- 12 September 2007
- journal article
- Published by Elsevier
- Vol. 1770 (12) , 1636-1650
- https://doi.org/10.1016/j.bbagen.2007.08.018
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- MicroRNAsCell, 2004
- Targeting RNA with Small-Molecule Drugs: Therapeutic Promise and Chemical ChallengesAccounts of Chemical Research, 2001
- Aminoglycoside binding to the hammerhead ribozyme: a general model for the interaction of cationic antibiotics with RNA 1 1Edited by J. KarnJournal of Molecular Biology, 1998
- Modulation of the rev-RRE interaction by aromatic heterocyclic compoundsBioorganic & Medicinal Chemistry, 1997
- Specific binding of aminoglycoside antibiotics to RNAChemistry & Biology, 1995
- Design and Synthesis of RNA-Specific Groove-Binding Cations: Implications for Antiviral Drug DesignJournal of Medicinal Chemistry, 1994
- The interaction of substituted 2‐phenylquinoline intercalates with poly(A) · poly(U): Classical and threading intercalation modes with RNABiopolymers, 1994
- The search for structure-specific nucleic acid-interactive drugs: Effects of compound structure on RNA versus DNA interaction strengthBiochemistry, 1993
- DAPI (4',6-diamidino-2-phenylindole) binds differently to DNA and RNA: minor-groove binding at AT sites and intercalation at AU sitesBiochemistry, 1992
- Gross rearrangements within the 5′-untranslated region of the picornaviral genomesNucleic Acids Research, 1990